ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$9.70
+0.12 (+1.25%)
Open$9.87
Previous Close$9.58
Day High$10.00
Day Low$9.55
52W High$14.53
52W Low$1.47
Volume—
Avg Volume871.2K
Market Cap237.77M
P/E Ratio—
EPS$-3.43
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
-16.1% upside
Current
$9.70
$9.70
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 567.1K | 1.13M | 14.43M |
| Net Income | -147,662,558 | -265,527,077 | -2,421,627 |
| Profit Margin | -26,045.0% | -24,742.8% | -16.8% |
| EBITDA | -154,251,730 | -292,785,501 | -2,990,686 |
| Free Cash Flow | — | — | -1,604,262 |
| Rev Growth | -50.0% | -50.0% | +14.0% |
| Debt/Equity | 0.00 | 0.00 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $251.64 | -1.05% | 118.2 | 429.58B |
| AMGN | Amgen Inc | $362.12 | +0.44% | 24.8 | 193.10B |
| GILD | Gilead Sciences Inc | $126.34 | +0.01% | 17.1 | 157.21B |
| VRTX | Vertex Pharmaceuticals Inc | $496.73 | -0.58% | 28.1 | 121.87B |
| REGN | Regeneron Pharmaceuticals | $623.54 | -1.31% | 15.0 | 66.35B |
| ALNY | Alnylam Pharmaceuticals Inc | $301.03 | +2.56% | 69.3 | 39.97B |